{"skill":{"slug":"eisas","displayName":"Eisas","summary":"Japanese pharmaceutical company specializing in CNS and oncology drugs, known for Alzheimer's treatments like Aricept and Leqembi in global markets.","tags":{"latest":"1.0.0"},"stats":{"comments":0,"downloads":135,"installsAllTime":0,"installsCurrent":0,"stars":0,"versions":1},"createdAt":1778015255282,"updatedAt":1778492854429},"latestVersion":{"version":"1.0.0","createdAt":1778015255282,"changelog":"eisas 1.0.0\n\n- Initial release highlighting Eisai as a leading Japanese pharmaceutical company focused on CNS drugs and oncology.\n- Includes a historical timeline from founding (1941) to latest neuroscience pipeline updates (2024).\n- Outlines business model, key therapeutic areas, and global partnerships (notably with Biogen).\n- Presents a moat analysis emphasizing Alzheimer's leadership and substantial R&D investment.\n- Shares key figures: revenue, R&D spend, employee count, and Leqembi's market impact.\n- Adds notable facts about company philosophy and decades-long Alzheimer’s research commitment.","license":"MIT-0"},"metadata":null,"owner":{"handle":"hanxueyuan","userId":"s17eht14r6y7ztwaw37n96ka7583eghn","displayName":"hanxueyuan","image":"https://avatars.githubusercontent.com/u/16717383?v=4"},"moderation":null}